Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
223 studies found for:    Paresthesia
Show Display Options
Rank Status Study
21 Terminated
Has Results
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Condition: Chemotherapy-Induced Peripheral Neuropathy
Interventions: Drug: Pregabalin;   Drug: Placebo
22 Recruiting Landmark Guided Midline Versus Pre-procedural Ultrasound Guided Paramedian at L5S1 for Spinal Anaesthesia
Condition: Anaesthesia
Interventions: Procedure: Conventional landmark guided midline spinal anaesthesia;   Procedure: pre-procedure ultrasound guided L5S1 paramedian spinal;   Device: spinal anaesthesia
23 Completed Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis
Conditions: Fatigue;   Radicular Pain;   Cognitive Dysfunction;   Paresthesia;   Paresis
Interventions: Drug: Doxycycline;   Drug: Placebo
24 Completed
Has Results
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
Conditions: Ovarian Neoplasms;   Breast Neoplasms;   Paresthesia
Intervention:
25 Unknown  Sensory Mapping Following Video-assisted Thoracic Surgery
Conditions: Paresthesia;   Dysesthesia;   Pain
Intervention:
26 Completed
Has Results
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
Conditions: Neuralgia;   Spinal Cord Injuries
Interventions: Drug: placebo;   Drug: pregabalin
27 Completed
Has Results
An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain
Condition: Chronic Refractory Neuropathic Pain
Intervention: Drug: Lacosamide
28 Active, not recruiting
Has Results
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230);   Drug: octreotide LAR 30mg;   Drug: lanreotide ATG 120mg
29 Recruiting NAPS: Non-awake Versus Awake Placement of Spinal Cord Stimulators
Conditions: Chronic Pain;   Sciatica;   Failed Back Surgery Syndrome
Interventions: Procedure: Awake;   Procedure: Non-Awake
30 Completed Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency
Condition: Venous Insufficiency
Interventions: Drug: Venocur Triplex®;   Drug: placebo
31 Unknown  Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
Condition: Raynaud Disease
Interventions: Drug: 0.9% nitroglycerin in TAM cream;   Drug: vehicle cream
32 Completed Study to Compare Different Formulations of AZD3355
Condition: Gastroesophageal Reflux Disease
Intervention: Drug: AZD3355
33 Recruiting Nerve Stimulator Versus Ultrasound-guided Interscalene Block for Shoulder Surgery
Condition: Pain
Interventions: Procedure: NS-guided interscalene block;   Procedure: US-guided interscalene block
34 Recruiting Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block
Conditions: Shoulder Arthroscopy;   Ultrasound-guided Interscalene Nerve Block
Intervention: Procedure: Interscalene block for shoulder arthroscopy
35 Unknown  Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neurotoxicity;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Other: placebo
36 Recruiting Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain
Condition: Chronic Pain
Intervention: Device: Neurostimulation device implantation
37 Completed XENOX – Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
Conditions: Metastases;   Colorectal Neoplasms;   Colorectal Carcinoma
Intervention: Drug: SR57746A
38 Completed Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
Conditions: Metastases;   Colorectal Neoplasms;   Colorectal Carcinoma
Interventions: Drug: xaliproden (SR57746A);   Drug: Placebo;   Drug: oxaliplatin
39 Completed Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers
Conditions: Peripheral Neuropathic Pain;   Nociceptive Pain
Interventions: Drug: AZD3161;   Drug: Lidocaine;   Drug: AZD3161 Placebo
40 Completed
Has Results
Non Interventional Study For Patients Treated With Somavert®
Condition: Acromegaly
Intervention: Other: Non Interventional Observation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years